About this trial
VATS/RATS is widely used for diagnosis and treatment of intrathoracic conditions. Despite many benefits, postoperative pain continues to be intense after VATS/RATS. The optimal strategy for pain management has not been defined. In this randomized, placebo-controlled, double-blinded clinical investigation, investigators hypothesize that 5 mcg/kg intrathecal morphine will decrease postoperative analgesic consumption and reduce pain.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18-80 years old
Undergoing elective video-assisted thoracoscopic or robotic assisted surgery for anatomical lung resection
General anesthesia with anticipated intraoperative extubation.
Disqualifiers
American Society of Anesthesiologists (ASA) classification of 4 or 5
Anticipated postoperative intubation
Significant liver disease
Preoperative use of intravenous inotropes and/or vasopressor support
Trial design
Parallel
Treatments tested in this trial
Morphine Sulfate
Drug5 mcg/kg intrathecal preservative free morphine sulfate
Placebo
Other interventionSterile saline, placebo
Treatment groups
Trial outcomes
Primary outcomes
Postoperative morphine equivalent consumption
Total MG of analgesic medications given converted to morphine
Secondary outcomes
Postoperative pain
Visual analog score between 0-10
Number of pain interventions
Number of times patient given medication for pain
Postoperative opioid related side effects
Nausea medication administration, airway events, urinary retention, pruritus medication given,
Self-reported patient satisfaction
American Pain Society Outcome Questionnaire
Sponsors and contacts
Click on the lead sponsor to view all of their trials.